4.0 Letter

Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab

Related references

Note: Only part of the references are listed.
Letter Dermatology

Treatment of severe refractory adult atopic dermatitis with ustekinumab

Rafael Puya et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)

Article Immunology

The IL-17 pathway as a major therapeutic target in autoimmune diseases

Yan Hu et al.

YEAR IN IMMUNOLOGY (2011)

Review Dermatology

The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis

Antonella Di Cesare et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)

Article Dermatology

Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis

Chizuko Koga et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)